Tivic Health Systems, Inc. (TIVC)
NASDAQ: TIVC · Real-Time Price · USD
0.846
-0.005 (-0.54%)
At close: Mar 9, 2026, 4:00 PM EDT
0.865
+0.019 (2.28%)
After-hours: Mar 9, 2026, 7:58 PM EDT
Tivic Health Systems Revenue
Tivic Health Systems had revenue of $146.00K in the quarter ending September 30, 2025, with 15.87% growth. This brings the company's revenue in the last twelve months to $482.00K, down -49.63% year-over-year. In the year 2024, Tivic Health Systems had annual revenue of $780.00K, down -33.67%.
Revenue (ttm)
$482.00K
Revenue Growth
-49.63%
P/S Ratio
4.43
Revenue / Employee
$68,857
Employees
7
Market Cap
2.14M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WORK Medical Technology Group LTD | 9.85M |
| Nuwellis | 8.17M |
| INVO Fertility | 6.94M |
| Biomerica | 4.46M |
| ENvue Medical | 2.69M |
| Catheter Precision | 730.00K |
| iTonic Holdings | 305.22K |
| Profusa | 75.00K |
TIVC News
- 5 days ago - Biotech Veteran Michael K. Handley Named CEO of Tivic Health Systems to Spearhead Strategic Expansion in Biopharma - Accesswire
- 19 days ago - Tivic and BARDA Continue Discussions of Entolimod for Acute Radiation Syndrome on March 10 - Accesswire
- 5 weeks ago - Tivic, BARDA Discuss Entolimod(TM) for Acute Radiation Syndrome at TechWatch Meeting - Accesswire
- 6 weeks ago - Tivic to Showcase Strategic Pivot and Forward Outlook on Advancing Entolimod(TM) to Commercialization at DealFlow Discovery Conference - Accesswire
- 6 weeks ago - Tivic CEO To Present at the Upcoming Emerging Growth's January 2026 Virtual Conference - Accesswire
- 2 months ago - Tivic Health Systems, Inc. (TIVC) Discusses Acquisition of Biomanufacturing Assets and Strategic Transformation Transcript - Seeking Alpha
- 2 months ago - Tivic Delivers 200x Scale-up in Manufacturing for Lead Drug Candidate Entolimod(TM) And Achieves Reproducible Yields, Potency and Purity - Accesswire
- 2 months ago - Tivic Announces Special Webcast To Discuss Its Recent Acquisition of CDMO Assets - Highlighting Near-Term Strategic Potential and Immediate Contributions to Accelerated Drug Development Timelines - Accesswire